Beyer-Sehlmeyer, G, Glei, M, Hartmann, E, Hughes, R, Persin, C, Bohm, V, Rowland, I, Schubert, R, Jahreis, G & Pool-Zobel, BL (2003) Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br J Nutr 90, 1057–1070.
Boffa, LC, Lupton, JR, Mariani, MR, Ceppi, M, Newmark, HL, Scalmati, A & Lipkin, M (1992) Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52, 5906–5912.
Carlini, EJ, Raftogianis, RB, Wood, TC, Jin, F, Zheng, W, Rebbeck, TR & Weinshilboum, RM (2001) Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11, 57–68.
Coyle, P, Philcox, JC, Carey, LC & Rofe, AM (2002) Metallothionein: the multipurpose protein. Cell Mol Life Sci 59, 627–647.
Cummings, JH (1981) Short chain fatty acids in the human colon. Gut 22, 763–779.
Eaton, DL & Bammler, TK (1999) Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49, 156–164.
Ebert, MN, Beyer-Sehlmeyer, G, Liegibel, UM, Kautenburger, T, Becker, TW & Pool-Zobel, BL (2001) Butyrate induces glutathione S-transferase in human colon cells and protects from genetic damage by 4-hydroxynonenal. Nutr Cancer 41, 156–164.
Ebert, MN, Klinder, A, Schäferhenrich, A, Peters, WHM, Sendt, W, Scheele, J & Pool-Zobel, BL (2003) Expression of glutathione S-transferases (GST) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24, 1637–1644.
Ellgard, L, Andersson, H, Bosaeus, I & Bosaeus, I (1997) Inulin and oligofructose do not influence the absorption of cholestrol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increase energy excretion in ileostomy subjects. Eur J Clin Nutr 45, 451–457.
Falany, CN (1997) Sulfation and sulfotransferases. Introduction: changing view of sulfation and the cytosolic sulfotransferases. FASEB J 11, 1–2.
Femia, AP, Luceri, C, Dolara, P, Giannini, A, Biggeri, A, Salvadori, M, Clune, Y, Collins, KJ, Paglierani, M & Caderni, G (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953–1960.
Hass, R, Busche, R, Luciano, L, Reale, E & Engelhardt, WV (1997) Lack of butyrate is associated with induction of Bax and subsequent apoptosis in the proximal colon of guinea pig. Gastroenterology 112, 875–881.
Hayes, JD, Flanagan, JU & Jowsey, IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45, 51–88.
Hayes, JD & Strange, RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61, 154–166.
Hughes, R & Rowland, IR (2001) Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 22, 43–47.
Johnson, IT, Williamson, G & Musk, SRR (1994) Anticarcinogenic factors in plant foods: a new class of nutrients? Nutr Res Rev 7, 175–204.
Kiessling, G, Schneider, J & Jahreis, G (2002) Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 56, 843–849.
Klinder, A, Forster, A, Caderni, G, Femia, AP & Pool-Zobel, BL (2004 a) Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr Cancer 49, 144–155.
Klinder, A, Gietl, E, Hughes, R, et al. (2004 b) Gut fermentation products of inulin-derived prebiotics beneficially modulate markers of tumour progression in human colon tumour cells. Int J Cancer Prev 1, 19–32.
Kruh, J (1982) Effects of sodium butyrate, a new pharmacological agent on cells in culture. Mol Cell Biochem 42, 65–82.
Lupton, JR (2004) Microbial degradation products influence colon cancer risk, the butyrate controversy. J Nutr 134, 479–482.
Maclean, KN, McKay, IA & Bustin, SA (1998) Differential effects of sodium butyrate on the transcription of the human TIS11 family of early-response genes in colorectal cancer cells. Br J Biomed Sci 55, 184–191.
Manderson, K, Pinart, M, Tuohy, KM, Grace, WE, Hotchkiss, AT, Widmer, W, Yadhav, MP, Gibson, GR & Rastall, RA (2005) In vitro determination of prebiotic properties of oligosaccharides derived from an orange juice manufacturing by-product stream. Appl Environ Microbiol 71, 8383–8389.
Manus, B, Adang, RP, Ambergen, AW, Brägelmann, R, Armbrecht, U & Stockbrügger, RW (1997) The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prev 6, 38–43.
Mast, N & Pikuleva, IA (2005) A simple and rapid method to measure cholesterol binding to P450s and other proteins. J Lipid Res 46, 1561–1568.
Patel, P, Nankova, BB & LaGamma, EF (2005) Butyrate, a gut-derived environmental signal, regulates tyrosine hydroxylase gene expression via a novel promoter element. Brain Res Dev Brain Res 160, 53–62.
Pfaffl, MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.
Pfaffl, MW, Horgan, GW & Dempfle, L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30, e36.
Pool-Zobel, BL (2005) Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 93, Suppl. 1, S73–S90.
Pool-Zobel, BL, Selvaraju, V, Sauer, J, Kautenburger, T, Kiefer, J, Richter, KK, Soom, M & Wolfl, S (2005 a) Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 26, 1064–1076.
Pool-Zobel, B, Veeriah, S & Bohmer, FD (2005 b) Modulation of xenobiotic metabolising enzymes by anticarcinogens – focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis 6. Mutat Res 591, 74–92.
Poulsen, M, Molck, AM & Jacobsen, BL (2002) Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats. Nutr Cancer 42, 194–205.
Roberfroid, MB (2005) Introducing inulin-type fructans. Br J Nutr 93, Suppl. 1, S13–S25.
Roediger, WEW (1989) The utilisation of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83, 424–429.
Rogler, G, Daig, R, Aschenbrenner, E, Vogl, D, Schlottmann, K, Falk, W, Gross, V, Scholmerich, J & Andus, T (1998) Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab Invest 78, 889–890.
Schäferhenrich, A, Sendt, W, Scheele, J, Kuechler, A, Liehr, T, Claussen, U, Rapp, A, Greulich, KO & Pool-Zobel, BL (2003) Endogenously formed cancer risk factors induce damage of p53 in human colon cells obtained from surgical samples. Food Chem Toxicol 41, 655–664.
Schneemann, BO (1999) Fiber, inulin and oligofructose: similarities and differences. Br J Nutr 129, 1424S–1427S.
Turesky, RJ, Lang, NP, Butler, MA, Teitel, CH & Kadlubar, FF (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12, 1839–1845.
Van Loo, J, Clune, Y, Bennett, M & Collins, JK (2005) The SYNCAN project: goals, set-up, first results and settings of the human intervention study. Br J Nutr 93, Suppl. 1, S91–S98.
Verghese, M, Rao, DR, Chawan, CB & Shackelford, L (2002) Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr 132, 2804–2808.
Verghese, M, Walker, LT, Shackelford, L, Chawan, CB & Van Loo, J (2003) .
Wang, X & Gibson, GR (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75, 373–380.